155 related articles for article (PubMed ID: 20517306)
1. Insulin-like growth factors and risk of kidney cancer in men.
Major JM; Pollak MN; Snyder K; Virtamo J; Albanes D
Br J Cancer; 2010 Jun; 103(1):132-5. PubMed ID: 20517306
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men.
Similä ME; Kontto JP; Virtamo J; Hätönen KA; Valsta LM; Sundvall J; Männistö S
Br J Nutr; 2019 Apr; 121(8):938-944. PubMed ID: 30898176
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China.
London SJ; Yuan JM; Travlos GS; Gao YT; Wilson RE; Ross RK; Yu MC
J Natl Cancer Inst; 2002 May; 94(10):749-54. PubMed ID: 12011225
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers.
Stolzenberg-Solomon RZ; Limburg P; Pollak M; Taylor PR; Virtamo J; Albanes D
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):438-44. PubMed ID: 15006921
[TBL] [Abstract][Full Text] [Related]
5. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
[TBL] [Abstract][Full Text] [Related]
7. Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women.
Probst-Hensch NM; Wang H; Goh VH; Seow A; Lee HP; Yu MC
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):739-46. PubMed ID: 12917205
[TBL] [Abstract][Full Text] [Related]
8. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
[TBL] [Abstract][Full Text] [Related]
9. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
10. Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States).
Li L; Yu H; Schumacher F; Casey G; Witte JS
Cancer Causes Control; 2003 Oct; 14(8):721-6. PubMed ID: 14674736
[TBL] [Abstract][Full Text] [Related]
11. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).
Harris TG; Strickler HD; Yu H; Pollak MN; Monrad ES; Travin MI; Xue X; Rohan TE; Kaplan RC
Growth Horm IGF Res; 2006 Apr; 16(2):86-92. PubMed ID: 16530441
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
13. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.
Ma J; Giovannucci E; Pollak M; Chan JM; Gaziano JM; Willett W; Stampfer MJ
J Natl Cancer Inst; 2001 Sep; 93(17):1330-6. PubMed ID: 11535708
[TBL] [Abstract][Full Text] [Related]
14. High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: a Mendelian randomization study.
Chen M; Tsai CW; Chang WS; Xiong GY; Xu Y; Bau DT; Gu J
Carcinogenesis; 2021 Jun; 42(6):826-830. PubMed ID: 33852723
[TBL] [Abstract][Full Text] [Related]
15. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factors and liver cancer risk in male smokers.
Major JM; Stolzenberg-Solomon RZ; Pollak MN; Snyder K; Virtamo J; Albanes D
Br J Cancer; 2010 Sep; 103(7):1089-92. PubMed ID: 20717109
[TBL] [Abstract][Full Text] [Related]
17. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden.
Palmqvist R; Hallmans G; Rinaldi S; Biessy C; Stenling R; Riboli E; Kaaks R
Gut; 2002 May; 50(5):642-6. PubMed ID: 11950809
[TBL] [Abstract][Full Text] [Related]
18. Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening with a 4-year interval.
Janssen JA; Wildhagen MF; Ito K; Blijenberg BG; Van Schaik RH; Roobol MJ; Pols HA; Lamberts SW; Schröder FH
J Clin Endocrinol Metab; 2004 Sep; 89(9):4391-6. PubMed ID: 15356036
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease.
Duron E; Funalot B; Brunel N; Coste J; Quinquis L; Viollet C; Belmin J; Jouanny P; Pasquier F; Treluyer JM; Epelbaum J; le Bouc Y; Hanon O
J Clin Endocrinol Metab; 2012 Dec; 97(12):4673-81. PubMed ID: 23015654
[TBL] [Abstract][Full Text] [Related]
20. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley WD; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
